美国司法部周一表示,沃尔格林联合博姿公司及其子公司已同意支付 3 亿美元,以了结美国方面关于该连锁药店非法开具数百万张无效的阿片类药物及其他受管制药物处方的指控。美国司法部在一份声明中称,如果沃尔格林公司在 2032 财年之前被出售、合并或转让,该公司还将额外欠美国 5000 万美元。责任编辑:郭明煜
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.